CHZ868
a type II JAK2 kinase inhibitor with antineoplastic activity; structure in first source
Networked: 5
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Andraos, Rita:
2 articles
(07/2015 - 07/2015)
|
2. | Baffert, Fabienne:
2 articles
(07/2015 - 07/2015)
|
3. | Dölemeyer, Arno:
2 articles
(07/2015 - 07/2015)
|
4. | Ebel, Nicolas:
2 articles
(07/2015 - 07/2015)
|
5. | Gaul, Christoph:
2 articles
(07/2015 - 07/2015)
|
6. | Hofmann, Francesco:
2 articles
(07/2015 - 07/2015)
|
7. | Mandon, Emeline:
2 articles
(07/2015 - 07/2015)
|
8. | Murakami, Masato:
2 articles
(07/2015 - 07/2015)
|
9. | Radimerski, Thomas:
2 articles
(07/2015 - 07/2015)
|
10. | Romanet, Vincent:
2 articles
(07/2015 - 07/2015)
|
Related Diseases
Related Drugs and Biologics